ginsenoside rh2 has been researched along with 3-methylcholanthrene in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (3-methylcholanthrene) | Trials (3-methylcholanthrene) | Recent Studies (post-2010) (3-methylcholanthrene) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 7,215 | 1 | 158 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | 3-methylcholanthrene (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.544 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, M; Ota, T; Tatsuka, M | 1 |
1 other study(ies) available for ginsenoside rh2 and 3-methylcholanthrene
| Article | Year |
|---|---|
Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Apoptosis; CDC2-CDC28 Kinases; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Ginsenosides; Methylcholanthrene; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Oncogene Protein pp60(v-src); Protein Serine-Threonine Kinases; Saponins; Tumor Cells, Cultured | 2001 |